Literature DB >> 15613109

PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis.

Pazit Kanter1, Aliza Zeidman, Jonathan Streifler, Victor Marmelstein, Einat Even-Sapir, Ur Metser, Gideon Y Stein, Amos M Cohen.   

Abstract

Neurolymphomatosis is a rare manifestation of progressive non-Hodgkin's lymphoma. A 44-yr-old man with diffuse large B-cell lymphoma presented with unilateral progressive peripheral sensorimotor neuropathy after the 7th cycle of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone) therapy. No pathology in the nervous system was evident by computerized tomography (CT), magnetic resonance imaging (MRI) of the head, spinal axis and plexuses and by repeated analysis of cerebrospinal fluid. However, the hybrid modality of positron emission tomography (PET) of fluorinated deoxyglucose (FDG) combined with CT scan (PET-CT) showed unilateral involvement of both the brachial and lumbosacral nervous plexuses. A complete recovery of neurological manifestations and normalization of PET-CT followed intensive chemotherapy with autologous stem cell transplantation. The diagnosis and localization of neurolymphomatosis may be supported by PET-CT imaging.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15613109     DOI: 10.1111/j.1600-0609.2004.00369.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  12 in total

Review 1.  Neurologic complications of non-Hodgkin's lymphoma.

Authors:  Pierre Giglio; Mark R Gilbert
Journal:  Curr Hematol Malig Rep       Date:  2006-12       Impact factor: 3.952

2.  Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report.

Authors:  Sigal Grisariu; Batia Avni; Tracy T Batchelor; Martin J van den Bent; Felix Bokstein; David Schiff; Outi Kuittinen; Marc C Chamberlain; Patrick Roth; Anatoly Nemets; Edna Shalom; Dina Ben-Yehuda; Tali Siegal
Journal:  Blood       Date:  2010-04-05       Impact factor: 22.113

3.  Changing PET/CT manifestation of neurolymphomatosis.

Authors:  Klaus Strobel; Bernhard Pestalozzi; Ilja Ciernik; Niklaus G Schaefer; Abbas Yousefi Koma; Thomas F Hany
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-06       Impact factor: 9.236

4.  A case of neurolymphomatosis involving cranial nerves: MRI and fusion PET-CT findings.

Authors:  Ji Hyun Kim; Jae Hong Jang; Seong-Beom Koh
Journal:  J Neurooncol       Date:  2006-04-28       Impact factor: 4.130

5.  Detection of widespread neurolymphomatosis with 18F-FDG PET.

Authors:  Emel Oztürk; Fikret Arpaci; Murat Kocaoğlu; Nuri Arslan; Nail Bulakbaşi; Mehmet Ozgüven
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-16       Impact factor: 9.236

6.  Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab.

Authors:  Hui K Gan; Arun Azad; Lawrence Cher; Paul L R Mitchell
Journal:  Neuro Oncol       Date:  2009-12-24       Impact factor: 12.300

7.  Neurolymphomatosis on F-18 FDG PET/CT and MRI Findings: A Case Report.

Authors:  Chae Moon Hong; Sang-Woo Lee; Hong Je Lee; Bong Il Song; Hae Won Kim; Sungmin Kang; Shin Young Jeong; Byeong-Cheol Ahn; Jaetae Lee; Yee Soo Chae
Journal:  Nucl Med Mol Imaging       Date:  2010-12-10

8.  Diagnostic Yield of FDG-PET/CT, MRI, and CSF Cytology in Non-Biopsiable Neurolymphomatosis as a Heralding Sign of Recurrent Non-Hodgkin's Lymphoma.

Authors:  Faiq Shaikh; Aubrey C Chan; Omer Awan; Nivedita Jerath; Chandan Reddy; Salman A Khan; Michael M Graham
Journal:  Cureus       Date:  2015-09-09

9.  Four rare extranodal sites seen on FDG PET/CT in a single patient of disseminated lymphoma.

Authors:  Ameya D Puranik; Archi Agrawal; Nilendu C Purandare; Sneha Shah; Venkatesh Rangarajan
Journal:  Indian J Med Paediatr Oncol       Date:  2013-04

10.  Bilateral trigeminal nerve recurrence of non-hodgkin lymphoma revealed with FDG PET/CT.

Authors:  Sabire Yılmaz; Sait Sağer; Feyza Sen; Metin Halac
Journal:  Indian J Nucl Med       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.